logo
    [Rheobase and chronaxy as indicators for the activity of tuberculous processes].
    0
    Citation
    0
    Reference
    10
    Related Paper
    To the Editor: Dr Mehta and colleagues1 reported that patients in the intensive care unit who received diuretics for acute renal failure (ARF) had a higher risk of dying and nonrecovery of renal function than those who did not.
    Renal replacement therapy
    Citations (10)
    Diagnosis and Treatment| August 01 1971 THE CRITICALLY ILL CHILD: ACUTE RENAL FAILURE Robert S. Dobrin; Robert S. Dobrin Department of Pediatrics, University of California, San Francisco, and San Francisco General Hospital Search for other works by this author on: This Site PubMed Google Scholar C. Duane Larsen; C. Duane Larsen Department of Pediatrics, University of California, San Francisco, and San Francisco General Hospital Search for other works by this author on: This Site PubMed Google Scholar Malcolm A. Holliday Malcolm A. Holliday Department of Pediatrics, University of California, San Francisco, and San Francisco General Hospital Search for other works by this author on: This Site PubMed Google Scholar Pediatrics (1971) 48 (2): 286–293. https://doi.org/10.1542/peds.48.2.286 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Twitter LinkedIn Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Robert S. Dobrin, C. Duane Larsen, Malcolm A. Holliday; THE CRITICALLY ILL CHILD: ACUTE RENAL FAILURE. Pediatrics August 1971; 48 (2): 286–293. 10.1542/peds.48.2.286 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search nav search search input Search input auto suggest search filter All PublicationsAll JournalsPediatricsHospital PediatricsPediatrics In ReviewNeoReviewsAAP Grand RoundsAAP NewsAll AAP Sites Search Advanced Search Topics: critically ill children, renal failure, acute This content is only available via PDF. Copyright © 1971 by the American Academy of Pediatrics1971 Article PDF first page preview Close Modal You do not currently have access to this content.
    Icon
    Citations (14)
    Lung volume reduction surgery appears to be helpful in some, but not all patients with advanced emphysema. Because there are few little published data on the indications, patient selection criteria, preoperative assessment, choice of surgical technique and long-term efficacy, further investigation is necessary before definitive recommendations can be made.
    Pathophysiology
    Citations (0)
    Aerosolized medications are used as airway clearance therapy to treat a variety of airway diseases. These guidelines were developed from a systematic review with the purpose of determining whether the use of these medications to promote airway clearance improves oxygenation and respiratory mechanics, reduces ventilator time and ICU stay, and/or resolves atelectasis/consolidation compared with usual care. Recombinant human dornase alfa should not be used in hospitalized adult and pediatric patients without cystic fibrosis. The routine use of bronchodilators to aid in secretion clearance is not recommended. The routine use of aerosolized N-acetylcysteine to improve airway clearance is not recommended. Aerosolized agents to change mucus biophysical properties or promote airway clearance are not recommended for adult or pediatric patients with neuromuscular disease, respiratory muscle weakness, or impaired cough. Mucolytics are not recommended to treat atelectasis in postoperative adult or pediatric patients, and the routine administration of bronchodilators to postoperative patients is not recommended. There is no high-level evidence related to the use of bronchodilators, mucolytics, mucokinetics, and novel therapy to promote airway clearance in these populations.
    Atelectasis
    Citations (35)